This study will involve 3 phases:

1)  Eligibility screening (online questionnaires)
2)  Information and consent meeting
3)  Experimental Phase

a) 13 days of at-home sleep monitoring

b) Laboratory session (6 hours)

c) Post-laboratory task completion (5 days at home – 20-30 mins per day)  

d) Return sleep monitoring device following 5 days at-home task completion

$200 remuneration for completion of all stages

You may be eligible to participate in this study if you:

-  are a healthy adult aged 18-49 years and are fluent in English,
-  do not speak French (conversational level),

- tend to fall asleep before 1am and wake up at/before 9am

-  do not have a diagnosis of posttraumatic stress disorder (PTSD),
-  have normal or corrected-to-normal vision,
-  do not have a diagnosis of any of the following psychiatric conditions: bipolar disorder, psychosis,
schizophrenia, depression, panic disorder or OCD, or any personality disorder
-  do not have a diagnosis of a sleep disorder
-  are not prescribed dexamphetamine or taking antidepressants/anti-anxiety medication and;
- do not have any neurological conditions (including epilepsy, migraines), history of stroke or acquired brain injury (with the exception of mild concussions involving loss of consciousness < 15 minutes)